Batavia Bioservices Opens Laboratory Facility in Greater Boston Area
Batavia Bioservices has decided to launch a US facility in Woburn, Massachusetts.
Menzo Havenga, President and CEO of Batavia, said: “We have been growing more than four hundred percent in the past two years in the Netherlands and to keep up with customer demand we have decided to launch a facility in the Boston area.” Christopher Yallop, COO, adds: “We have chosen the greater Boston area due to its importance as a biotech cluster. Positioning ourselves here allows us to be close to our customers, which we deem extremely important in delivering on time and on budget.” Batavia Bioservices provides a one-stop shop from DNA cloning to Phase I/II clinical manufacturing for all major classes of biopharmaceuticals, including antibodies, proteins or vaccines.
The Woburn facility (± 5500 sq feet), located at Cummings Properties’ TradeCenter 128, contains multiple BSL-2 laboratories dedicated to specific tasks including Molecular Biology, mammalian cell line generation, protein production, protein purification or assay development. The company has already hired six employees for the new facility, with plans to hire four more by the end of this year. Joan Hilly, Director Cell Sciences, said: “It’s great that we have been able to quickly staff our facility with experts in their respective fields and in fact we have just started executing the first customer contracts on site!”
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.